Sfoglia per Rivista RADIOTHERAPY AND ONCOLOGY
Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins
2018-01-01 Levis, Mario; DE LUCA, Viola; Fiandra, Christian; Veglia, Simona; Fava, Antonella; Gatti, Marco; Giorgi, Mauro; Bartoncini, Sara; Cadoni, Federica; Garabello, Domenica; Ragona, Riccardo; Filippi, Andrea Riccardo; Ricardi, Umberto
PO-0859 Validation of genetic variants associated to late severe toxicity after prostate cancer RT
2019-01-01 Cicchetti, A.; Rancati, T.; Ballarini, F.; Dispinzieri, M.; Giandini, T.; Avuzzi, B.; Cozzarini, C.; Fiorino, C.; Valdagni, R.
PO-1069 RBE calculation for hadrontherapy by the BIANCA biophysical model
2019-01-01 Carante, M. P.; Ballarini, F.
Radiotherapy and immune checkpoints inhibitors for advanced melanoma
2016-01-01 Filippi, Andrea Riccardo; Fava, Paolo; Badellino, Serena; Astrua, Chiara; Ricardi, Umberto; Quaglino, Pietro
RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes
2019-01-01 Molinelli, S.; Bonora, M.; Magro, G.; Casale, Silvia; Dale, J. E.; Fossati, P.; Hasegawa, A.; Mirandola, A.; Ronchi, S.; Russo, S.; Preda, L.; Valvo, F.; Orecchia, R.; Ciocca, M.; Vischioni, B.
Role of DNA organisation and environmental conditions in the evolutions of radiobiological damage: models and simulations
2004-01-01 Ballarini, Francesca; Friedland, W.; Jacob, P.; Ottolenghi, ANDREA DAVIDE; Paretzke, H. G.; Scannicchio, Domenico; Valota, A.
Surgical spacer for sacral chordoma carbon ion treatment at CNAO
2016-01-01 Vischioni, B; Fiore, M; Fossati, P; Vitolo, V; Iannalfi, A; Ciurlia, E; Bonora, M; Panizza, D; Ciocca, M; Cobianchi, L; Peloso, A; Dominioni, T; Bugada, D; Dionigi, P; Valvo, F; Orecchia, R
THE ALLEGRO PROJECT: AN OVERVIEW
2011-01-01 Ottolenghi, ANDREA DAVIDE; Trott, KLAUS RUDIGER; Smyth, VERE GERALD
The ALLEGRO project: what is the relevance of second cancers after oncological treatment, and which information is required?
2010-01-01 W., Dörr; M., Durante; F., Van den Heuvel; Trott, KLAUS RUDIGER; Smyth, VERE GERALD; Ottolenghi, ANDREA DAVIDE
The ALLEGRO project: what more do we need to know about normal tissue complication probability?
2010-01-01 H., Langendijk; F., Van den Heuvel; Trott, KLAUS RUDIGER; Smyth, VERE GERALD; Ottolenghi, ANDREA DAVIDE
The ANDANTE project: refining risk estimates from neutrons
2012-01-01 Ottolenghi, ANDREA DAVIDE; Smyth, VERE GERALD; Trott, KLAUS RUDIGER
The risk of second cancers following proton therapy.
2012-01-01 Trott, KLAUS RUDIGER; G., Hildebrandt; Ottolenghi, ANDREA DAVIDE; Smyth, VERE GERALD
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins | 1-gen-2018 | Levis, Mario; DE LUCA, Viola; Fiandra, Christian; Veglia, Simona; Fava, Antonella; Gatti, Marco; Giorgi, Mauro; Bartoncini, Sara; Cadoni, Federica; Garabello, Domenica; Ragona, Riccardo; Filippi, Andrea Riccardo; Ricardi, Umberto | |
| PO-0859 Validation of genetic variants associated to late severe toxicity after prostate cancer RT | 1-gen-2019 | Cicchetti, A.; Rancati, T.; Ballarini, F.; Dispinzieri, M.; Giandini, T.; Avuzzi, B.; Cozzarini, C.; Fiorino, C.; Valdagni, R. | |
| PO-1069 RBE calculation for hadrontherapy by the BIANCA biophysical model | 1-gen-2019 | Carante, M. P.; Ballarini, F. | |
| Radiotherapy and immune checkpoints inhibitors for advanced melanoma | 1-gen-2016 | Filippi, Andrea Riccardo; Fava, Paolo; Badellino, Serena; Astrua, Chiara; Ricardi, Umberto; Quaglino, Pietro | |
| RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes | 1-gen-2019 | Molinelli, S.; Bonora, M.; Magro, G.; Casale, Silvia; Dale, J. E.; Fossati, P.; Hasegawa, A.; Mirandola, A.; Ronchi, S.; Russo, S.; Preda, L.; Valvo, F.; Orecchia, R.; Ciocca, M.; Vischioni, B. | |
| Role of DNA organisation and environmental conditions in the evolutions of radiobiological damage: models and simulations | 1-gen-2004 | Ballarini, Francesca; Friedland, W.; Jacob, P.; Ottolenghi, ANDREA DAVIDE; Paretzke, H. G.; Scannicchio, Domenico; Valota, A. | |
| Surgical spacer for sacral chordoma carbon ion treatment at CNAO | 1-gen-2016 | Vischioni, B; Fiore, M; Fossati, P; Vitolo, V; Iannalfi, A; Ciurlia, E; Bonora, M; Panizza, D; Ciocca, M; Cobianchi, L; Peloso, A; Dominioni, T; Bugada, D; Dionigi, P; Valvo, F; Orecchia, R | |
| THE ALLEGRO PROJECT: AN OVERVIEW | 1-gen-2011 | Ottolenghi, ANDREA DAVIDE; Trott, KLAUS RUDIGER; Smyth, VERE GERALD | |
| The ALLEGRO project: what is the relevance of second cancers after oncological treatment, and which information is required? | 1-gen-2010 | W., Dörr; M., Durante; F., Van den Heuvel; Trott, KLAUS RUDIGER; Smyth, VERE GERALD; Ottolenghi, ANDREA DAVIDE | |
| The ALLEGRO project: what more do we need to know about normal tissue complication probability? | 1-gen-2010 | H., Langendijk; F., Van den Heuvel; Trott, KLAUS RUDIGER; Smyth, VERE GERALD; Ottolenghi, ANDREA DAVIDE | |
| The ANDANTE project: refining risk estimates from neutrons | 1-gen-2012 | Ottolenghi, ANDREA DAVIDE; Smyth, VERE GERALD; Trott, KLAUS RUDIGER | |
| The risk of second cancers following proton therapy. | 1-gen-2012 | Trott, KLAUS RUDIGER; G., Hildebrandt; Ottolenghi, ANDREA DAVIDE; Smyth, VERE GERALD |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile